A. Sarici, M. Erkurt, I. Kuku, E. Kaya, İ. Berber, S. Biçim, Emine Hidayet, Ahmet Kaya, Ömer Faruk Bahçecíoğlu, L. Tanrıverdi, S. Özkan
{"title":"伊布替尼治疗异基因造血干细胞移植患者慢性移植物抗宿主病的经验:单中心经验","authors":"A. Sarici, M. Erkurt, I. Kuku, E. Kaya, İ. Berber, S. Biçim, Emine Hidayet, Ahmet Kaya, Ömer Faruk Bahçecíoğlu, L. Tanrıverdi, S. Özkan","doi":"10.4274/imj.galenos.2023.98370","DOIUrl":null,"url":null,"abstract":"allo-HSCT","PeriodicalId":42584,"journal":{"name":"Istanbul Medical Journal","volume":" ","pages":""},"PeriodicalIF":0.2000,"publicationDate":"2023-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Experience of Ibrutinib in Chronic Graft-Versus-Host Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: Single Center Experience\",\"authors\":\"A. Sarici, M. Erkurt, I. Kuku, E. Kaya, İ. Berber, S. Biçim, Emine Hidayet, Ahmet Kaya, Ömer Faruk Bahçecíoğlu, L. Tanrıverdi, S. Özkan\",\"doi\":\"10.4274/imj.galenos.2023.98370\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"allo-HSCT\",\"PeriodicalId\":42584,\"journal\":{\"name\":\"Istanbul Medical Journal\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.2000,\"publicationDate\":\"2023-05-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Istanbul Medical Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4274/imj.galenos.2023.98370\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Istanbul Medical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4274/imj.galenos.2023.98370","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
The Experience of Ibrutinib in Chronic Graft-Versus-Host Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: Single Center Experience